Now that genomes can be sequenced for $1,000, more patients can benefit, says Howard Jacob.
Apple’s always-on motion-sensing M7 chip points the way to an era of mobile gesture-recognition and “ambient intelligence.”
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
The U.S. has plenty of the metals that are critical to many green-energy technologies, but engineering and R&D expertise have moved overseas.
In much of the world, the concept of “net neutrality” generates less public debate, given there’s no affordable Net in the first place.
Serious games are becoming increasingly popular, but the inability to generate realistic new content has hampered their progress. Until now.
Drugs can control HIV, but they exact a steep cost. Now, researchers are pursuing radical new ways to eliminate the infection entirely.
Hostility to the use of wearable computers and cameras threatens to limit their benefits, says Steve Mann.